Depression and Anxiety Trial, Recruiting NCT05630469 Sponsor: Medical University of Vienna Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT05630469
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 to 65 years old who are currently admitted to hospital as inpatients
  • People who have been diagnosed with severe unipolar (non-bipolar) depression, using specific ICD-10 codes (F32.2, F32.3, F33.2, or F33.3)
  • People whose depression scores at least 23 on a standard rating scale called the HAMD17, indicating severe symptoms
  • People who are in good general physical health
  • People who are able to understand the trial information and are willing to sign a consent form
  • People whose drug screening test comes back negative, and, for women, whose urine pregnancy test comes back negative
  • People who have been on a stable dose of antidepressant or antipsychotic medication for at least 10 days before entering the trial
  • People who have been cleared by an anaesthesiologist (a specialist doctor) as suitable to receive ECT (electroconvulsive therapy)

Who may not be able to join:

  • People with a serious physical illness or a serious neurological (brain or nerve) condition
  • People who currently have another psychiatric diagnosis alongside their depression, including bipolar depression (as defined by DSM-5 criteria)
  • People who currently have, or have ever had, a diagnosis of schizophrenia or schizoaffective disorder
  • People who are currently misusing alcohol, recreational drugs, or any medication in a way that suggests ongoing abuse, or who meet the DSM-5 criteria for alcohol or substance dependence
  • People who have clinically significant abnormal results on a general physical examination or routine blood tests
  • People who are pregnant or breastfeeding
  • People for whom a lumbar puncture (spinal tap) would not be safe — for example, due to raised pressure in the brain, blood-thinning medication, a bleeding or clotting disorder, a spine abnormality present from birth, a recent spine injury or surgery, or a skin infection at the puncture site
  • People who have any implant or stainless steel surgical graft in their body that would make an MRI scan unsafe

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +43 1 40400 35350

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 December 2022
Est. completion
30 May 2026

Where this trial is recruiting

🇦🇹 Austria

Primary endpoints

imaging parameter - sMRI; imaging parameters - DTI; imaging parameters - fMRI; imaging parameters - rsfMRI; imaging parameters - MRS; biochemical parameters - neurodegeneration; biochemical parameters - inflammation; biochemical parameters - neurplasticity; response prediction

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov